Page last updated: 2024-11-02

pamidronate and Abnormalities, Multiple

pamidronate has been researched along with Abnormalities, Multiple in 3 studies

Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.

Research Excerpts

ExcerptRelevanceReference
" Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented."7.78Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012)
" Here, a case of a 9-year-old girl with familial HCS and multiple spinal fractures, who has been effectively treated with pamidronate, is presented."3.78Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. ( Galli-Tsinopoulou, A; Giannopoulou, EZ; Giza, S; Kyrgios, I; Laliotis, N; Maggana, I, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galli-Tsinopoulou, A1
Kyrgios, I1
Giza, S1
Giannopoulou, EZ1
Maggana, I1
Laliotis, N1
Bayram, F1
Tanriverdi, F1
Kurtoğlu, S1
Atabek, ME1
Kula, M1
Kaynar, L1
Keleştimur, F1
Phadke, SR1
Ramirez, M1
DiFeo, A1
Martignetti, JA1
Girisha, KM1

Trials

1 trial available for pamidronate and Abnormalities, Multiple

ArticleYear
Torg-Winchester syndrome: lack of efficacy of pamidronate therapy.
    Clinical dysmorphology, 2007, Volume: 16, Issue:2

    Topics: Abnormalities, Multiple; Bone Density; Bone Density Conservation Agents; Bone Diseases, Developmenta

2007

Other Studies

2 other studies available for pamidronate and Abnormalities, Multiple

ArticleYear
Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.
    Minerva endocrinologica, 2012, Volume: 37, Issue:3

    Topics: Abnormalities, Multiple; Acro-Osteolysis; Bone Density; Bone Density Conservation Agents; Child; Dip

2012
Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Journal of pediatric endocrinology & metabolism : JPEM, 2006, Volume: 19, Issue:3

    Topics: Abnormalities, Multiple; Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Central

2006